FDC
Back to Income Statement
|
FDC Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹2,108 Cr | ₹1,943 Cr | ₹1,784 Cr | ₹1,528 Cr | ₹1,333 Cr |
What is the latest Revenue of FDC ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹2,108 Cr |
| Mar2024 | ₹1,943 Cr |
| Mar2023 | ₹1,784 Cr |
| Mar2022 | ₹1,528 Cr |
| Mar2021 | ₹1,333 Cr |
How is Revenue of FDC Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,108 Cr | 8.50 | |
| Mar2024 | ₹1,943 Cr | 8.92 | |
| Mar2023 | ₹1,784 Cr | 16.74 | |
| Mar2022 | ₹1,528 Cr | 14.61 | |
| Mar2021 | ₹1,333 Cr | - | |
Compare Revenue of peers of FDC
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| FDC | ₹6,026.9 Cr | -8.2% | -14.3% | -22.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹467,630.0 Cr | -0.1% | 0.5% | 14% | Stock Analytics | |
| DIVIS LABORATORIES | ₹218,972.0 Cr | -0.9% | 21.1% | 25.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,358.0 Cr | -1.3% | 1.1% | 32.7% | Stock Analytics | |
| CIPLA | ₹118,916.0 Cr | 0.2% | 2.1% | -5.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,824.0 Cr | 0.2% | -7.7% | -7.5% | Stock Analytics | |
FDC Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| FDC | -8.2% |
-14.3% |
-22.6% |
| SENSEX | 0.5% |
2.6% |
-3.7% |
You may also like the below Video Courses